Feb 08, 2021
Patients with rare cancers have access to hard-to-find targeted cancer therapies, support services through AllianceRx Walgreens Prime
Dec 17, 2020
Kesimpta® available through AllianceRx Walgreens Prime for adults with relapsing multiple sclerosis
Nov 16, 2020
Newest clinical assessment tool allows AllianceRx Walgreens Prime cancer patients to manage care online
Oct 29, 2020
AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases
Oct 01, 2020
AllianceRx Walgreens Prime implements industry-leading data supplementation capabilities focused on advanced efficiency and patient care
Sep 16, 2020
Rick Miller receives National Association of Specialty Pharmacy (NASP) Distinguished Service Award for significant contributions to NASP leadership, specialty pharmacy industry
Aug 27, 2020
Inqovi available for blood cancer patients to receive at home through AllianceRx Walgreens Prime
Aug 06, 2020
AllianceRx Walgreens Prime is the only specialty pharmacy to use a patented process for shipping temperature-sensitive medicine
May 19, 2020
AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute Vyepti(TM), the first and only intravenous preventive treatment for migraine
May 11, 2020
AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients
May 06, 2020
AllianceRx Walgreens Prime renews sponsorship of web-based continuing education for specialty pharmacists through National Association of Specialty Pharmacy and ProCE, Inc.
Jan 06, 2020
New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime
Nov 06, 2019
AllianceRx Walgreens Prime study demonstrates favorable adherence, but high cost for cystic fibrosis patients prescribed modulator medications
Oct 28, 2019
AllianceRx Walgreens Prime names new chief operations officer
Sep 24, 2019
AllianceRx Walgreens Prime earns specialty pharmacy reaccreditation from ACHC
Sep 11, 2019
AllianceRx Walgreens Prime study demonstrates increased adherence and improvement in symptoms for psoriasis patients switching to interleukin-17 inhibitors
Aug 16, 2019
AllianceRx Walgreens Prime Issues Updated List of New Specialty Drugs
Aug 12, 2019
Medicines targeting multiple sclerosis and lymphoma are among new specialty drugs available through AllianceRx Walgreens Prime
Mar 26, 2019
AllianceRx Walgreens Prime study demonstrates oral oncology split-fill program drives adherence, reduces costs and decreases medication waste
Mar 26, 2019
Patients with hemophilia A benefit from preventive use of newer FDA-approved extended half-life therapies